Quick answer
Protagonist Therapeutics, Inc (PTGX) reported diluted EPS of $2.29 for the quarter ended 2026-06-30, in a 10-Q filed with the SEC on 2026-08-05. Its last four 10-Q/10-K filings were on 2026-08-05, 2026-05-05, 2026-02-25, 2025-11-06.
Data as of 2026-08-05. Source: SEC EDGAR XBRL company facts (10-K/10-Q filings)
| Period end | Period | Form | SEC filing date | Diluted EPS |
|---|---|---|---|---|
| 2026-06-30 | Quarter | 10-Q | 2026-08-05 | $2.29 |
| 2026-03-31 | Quarter | 10-Q | 2026-05-05 | $0.05 |
| 2025-12-31 | Full year | 10-K | 2026-02-25 | $-2.05 |
| 2025-09-30 | Quarter | 10-Q | 2025-11-06 | $-0.62 |
| 2025-06-30 | Quarter | 10-Q | 2025-08-06 | $-0.55 |
| 2025-03-31 | Quarter | 10-Q | 2025-05-06 | $-0.19 |
| 2024-12-31 | Full year | 10-K | 2025-02-21 | $4.23 |
| 2024-09-30 | Quarter | 10-Q | 2024-11-07 | $-0.54 |
| 2024-06-30 | Quarter | 10-Q | 2024-08-06 | $-0.50 |
| 2024-03-31 | Quarter | 10-Q | 2024-05-07 | $3.26 |
| 2023-12-31 | Full year | 10-K | 2024-02-27 | $-1.39 |
| 2023-09-30 | Quarter | 10-Q | 2023-11-02 | $-0.58 |
| 2023-06-30 | Quarter | 10-Q | 2023-08-03 | $-0.68 |
| 2023-03-31 | Quarter | 10-Q | 2023-05-04 | $-0.67 |
| 2022-12-31 | Full year | 10-K | 2023-03-15 | $-2.60 |
| 2022-09-30 | Quarter | 10-Q | 2022-11-08 | $-0.64 |
Related
- PSA earnings report dates and EPS history (Public Storage)
- PSX earnings report dates and EPS history (Phillips 66)
- PTC earnings report dates and EPS history (PTC Inc.)
- PWR earnings report dates and EPS history (Quanta Services, Inc.)
- PYPL earnings report dates and EPS history (PayPal Holdings, Inc.)
- Q earnings report dates and EPS history (Qnity Electronics, Inc.)
- QCOM earnings report dates and EPS history (Qualcomm Inc/De)
- QSR earnings report dates and EPS history (Restaurant Brands International Inc.)
Last updated 2026-10-16. Data only, not financial or tax advice.